[On the effectiveness of a combined clarifying-fibrinolytic therapy in the preventive and curative treatment of arteriosclerosis and its sequelae].
D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy; D001205:Ascorbic Acid / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D009539:Nicotinic Acids / Q000494:pharmacology*; D010908:Pituitary Hormones, Anterior / Q000627:therapeutic use*; D013923:Thromboembolism / Q000188:drug therapy*; D008083:beta-Lipotropin / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D009539:Nicotinic Acids; D010908:Pituitary Hormones, Anterior; D006493:Heparin; D008083:beta-Lipotropin; D001205:Ascorbic Acid
Sull'efficacia di una terapia fibrinolitica chiarificante di associazione nel trattamento preventivo e curativo dell' arteriosclerosi e delle sue conseguenze.